Maccura Biotech expands dealer guarantees with new pledges

Maccura Biotechnology Co., Ltd. (Maccura Biotech) recently expanded its guarantee commitments for two key dealers, Chengdu Huize Biological Technology Co., Ltd. and Chengdu Maibangyuan Biological Technology Co., Ltd., through agreements with Industrial Bank Co., Ltd. Chengdu Branch. This move is part of a broader strategy, approved in late 2025, to provide up to RMB 350 million in rolling guarantees to qualified dealers.

Under the new agreements, Maccura Biotech provided a RMB 30 million guarantee for Chengdu Huize Biological Technology, bringing the total approved guarantee for this entity to RMB 50 million. Additionally, a RMB 16 million guarantee was extended to Chengdu Maibangyuan Biological Technology, raising its total approved guarantee to RMB 30 million, with a current outstanding balance of RMB 11 million. These guarantees are structured as joint and several liability, effective for three years from the date of each underlying loan.

As of the announcement date, Maccura Biotech’s total external guarantee exposure, including its subsidiaries, amounts to RMB 1.15 billion, representing 18.06% of its audited net assets as of December 31, 2024. The actual outstanding guarantee balance for the company and its subsidiaries is RMB 458.9166 million. Maccura Biotech reports no overdue or disputed guarantees.